Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Natera Inc (NTRA)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 1
  • 1 comments

Natera - Natera to Report its Second Quarter Results on August 6, 2026

Market reaction Comment Full text

ELASTIC N.V. (ESTC)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Elastic and OpenAI Collaborate to Bring Frontier Intelligence to Unstructured Enterprise Data

Market reaction Comment Full text

TERRESTRIAL ENERGY INC. /DE/ (IMSR)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Terrestrial Energy Appoints Senior Industry Executive Pamela Cowan as EVP of Engineering

Market reaction Comment Full text

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress

Market reaction Comment Full text

PIPER SANDLER COMPANIES (PIPR)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Piper Sandler Companies Reports Second Quarter 2026 Results; Declares Quarterly Dividend of $0.20 Per Share

Market reaction Comment Full text

LINEAGE CELL THERAPEUTICS INC. (LCTX)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

Market reaction Comment Full text

NATERA, INC. (NTRA)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Natera to Report its Second Quarter Results on August 6, 2026

Market reaction Comment Full text

INFORMATION SERVICES GROUP INC. (III)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Empresas brasileiras reformulam estratégias de nuvem para IA

Market reaction Comment Full text

LEIDOS HOLDINGS, INC. (LDOS)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Leidos and CoreWeave Collaborate to Accelerate Delivery of AI Capabilities for Defense, National Security and Intelligence Missions

Market reaction Comment Full text

EVOMMUNE, INC. (EVMN)

  • Business News
  • July 30, 2026, 12:00 UTC
  • 0
  • 1 comments

Evommune Initiates Phase 2b Clinical Trial of MRGPRX2 Inhibitor EVO756 in Migraine Prophylaxis

Market reaction Comment Full text
  • Previous
  • 63
  • 64
  • 65
  • 66
  • 67
  • Next

Search

News categories

  • Technical Exchange News(14017)
  • Event(6229)
  • SEC News(356696)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(216040)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin